These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 16801564)

  • 21. Exercise and risk factors associated with metabolic syndrome in older adults.
    Stewart KJ; Bacher AC; Turner K; Lim JG; Hees PS; Shapiro EP; Tayback M; Ouyang P
    Am J Prev Med; 2005 Jan; 28(1):9-18. PubMed ID: 15626550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community center-based resistance training for the maintenance of glycemic control in adults with type 2 diabetes.
    Dunstan DW; Vulikh E; Owen N; Jolley D; Shaw J; Zimmet P
    Diabetes Care; 2006 Dec; 29(12):2586-91. PubMed ID: 17130189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in metabolic parameters and microalbuminuria in patients with type 2 diabetes treated with acarbose].
    González Sarmiento E; Ergueta Martín P; Fernández Martínez I; Hinojosa Mena-Bernal MC; Zurro Muñoz I; Zurro Hernández J
    An Med Interna; 2001 May; 18(5):234-6. PubMed ID: 11496556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body fat distribution modulates insulin sensitivity in post-menopausal overweight and obese women: a MONET study.
    Tousignant B; Faraj M; Conus F; Garrel D; Brochu M; Rabasa-Lhoret R; Coderre L
    Int J Obes (Lond); 2008 Nov; 32(11):1626-32. PubMed ID: 18838980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P;
    Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of statins potentiates the insulin-sensitizing effect of exercise training in obese males with and without Type 2 diabetes.
    Meex RC; Phielix E; Schrauwen-Hinderling VB; Moonen-Kornips E; Schaart G; Schrauwen P; Hesselink MK
    Clin Sci (Lond); 2010 Jun; 119(7):293-301. PubMed ID: 20465545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes.
    Barnard ND; Cohen J; Jenkins DJ; Turner-McGrievy G; Gloede L; Jaster B; Seidl K; Green AA; Talpers S
    Diabetes Care; 2006 Aug; 29(8):1777-83. PubMed ID: 16873779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise is good for your blood pressure: effects of endurance training and resistance training.
    Fagard RH
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):853-6. PubMed ID: 16922820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
    De Pergola G; Pannacciulli N; Coviello M; Scarangella A; Di Roma P; Caringella M; Venneri MT; Quaranta M; Giorgino R
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):227-32. PubMed ID: 17400434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients.
    Ersoy C; Kiyici S; Budak F; Oral B; Guclu M; Duran C; Selimoglu H; Erturk E; Tuncel E; Imamoglu S
    Diabetes Res Clin Pract; 2008 Jul; 81(1):56-60. PubMed ID: 18358555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of caloric restriction with and without exercise training on oxidative stress and endothelial function in obese subjects with type 2 diabetes.
    Wycherley TP; Brinkworth GD; Noakes M; Buckley JD; Clifton PM
    Diabetes Obes Metab; 2008 Nov; 10(11):1062-73. PubMed ID: 18435772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study.
    Aubertin-Leheudre M; Lord C; Khalil A; Dionne IJ
    Menopause; 2007; 14(4):624-9. PubMed ID: 17290158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects.
    Davison K; Coates AM; Buckley JD; Howe PR
    Int J Obes (Lond); 2008 Aug; 32(8):1289-96. PubMed ID: 18504447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB; Fonseca VA; Truitt KE; Jones MR
    Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes.
    Toledo FG; Menshikova EV; Ritov VB; Azuma K; Radikova Z; DeLany J; Kelley DE
    Diabetes; 2007 Aug; 56(8):2142-7. PubMed ID: 17536063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of exercise training on glucose control, lipid metabolism, and insulin sensitivity in hypertriglyceridemia and non-insulin dependent diabetes mellitus.
    Lampman RM; Schteingart DE
    Med Sci Sports Exerc; 1991 Jun; 23(6):703-12. PubMed ID: 1886478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes.
    Zeymer U
    Int J Cardiol; 2006 Feb; 107(1):11-20. PubMed ID: 16337493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of acarbose treatment on markers of insulin sensitivity and systemic inflammation.
    Rudovich NN; Weickert MO; Pivovarova O; Bernigau W; Pfeiffer AF
    Diabetes Technol Ther; 2011 Jun; 13(6):615-23. PubMed ID: 21488802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.
    Chisalita SI; Lindström T; Eson Jennersjö P; Paulsson JF; Westermark GT; Olsson AG; Arnqvist HJ
    Acta Diabetol; 2009 Mar; 46(1):35-42. PubMed ID: 18777156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of acarbose on postmeal mononuclear blood cell response in patients with early type 2 diabetes: the AI(I)DA study.
    Hanefeld M; Schaper F; Koehler C; Bergmann S; Ugocsai P; Stelzer J; Schmitz G
    Horm Metab Res; 2009 Feb; 41(2):132-6. PubMed ID: 19214923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.